Virtual control groups in non-clinical toxicology – A replicability challenge By VICT3R|2025-04-29T13:26:54+02:00April 29th, 2025| Read More
Scientific and Regulatory Policy Committee Points to Consider: Proposal and Recommendations to Reduce Euthanasia of Control Nonhuman Primates in Nonclinical Toxicity Studies By VICT3R|2025-09-10T15:20:56+02:00April 1st, 2025| Read More
Virtual Control Groups in Non-clinical Toxicity Studies: Impacts on Toxicologic Clinical Pathology Data Interpretation By VICT3R|2025-06-25T10:20:47+02:00April 1st, 2025| Read More
Perspectives on Implementing Virtual Control Groups in Developmental and Reproductive Toxicity Studies By VICT3R|2025-06-03T11:00:42+02:00March 2nd, 2025| Read More
Mapping out strategies to further develop human-relevant, new approach methodology (NAM)-based developmental neurotoxicity (DNT) testing By VICT3R|2025-04-22T13:39:11+02:00March 2nd, 2025| Read More
Innovative Medicines Initiative public–private partnerships to enhance translational safety By VICT3R|2025-06-03T11:00:52+02:00March 1st, 2025| Read More
Building a Roadmap for AI-Enabled Human and Environmental Health Protection By VICT3R|2025-09-10T15:18:47+02:00March 1st, 2025| Read More
Use and reporting of historical control data for regulatory studies By VICT3R|2025-09-10T15:17:36+02:00March 1st, 2025| Read More
Using pre-existing control data to set expectations in preclinical studies By VICT3R|2025-08-19T15:18:56+02:00March 1st, 2025| Read More